APTIVUS vs LAMIVUDINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. APTIVUS and LAMIVUDINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	APTIVUS	LAMIVUDINE
Rating	72/100	66/100
Pharmacy pays	—	$0.44 /mL
Type	RX	RX
Active ingredient	TIPRANAVIR	LAMIVUDINE
Manufacturer	Boehringer Ingelheim	Apotex
Dosage forms	Capsule	Tablet
Drug class	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Boxed warning	None	Boxed warning
Treats	Acquired Immunodeficiency Syndrome	Acquired Immunodeficiency Syndrome

aptivus lamivudine

Rating

72/100

66/100

Pharmacy pays

—

$0.44 /mL

Type

Active ingredient

TIPRANAVIR

LAMIVUDINE

Manufacturer

Boehringer Ingelheim

Apotex

Dosage forms

Capsule

Tablet

Drug class

—

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Boxed warning

None

Boxed warning

Treats

Acquired Immunodeficiency Syndrome

Frequently asked questions

Which is better-rated, Aptivus or Lamivudine?

By our independent rating, Aptivus scores higher — 3.6 vs 3.3 out of 5 for Lamivudine. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Aptivus and Lamivudine?

Aptivus contains Tipranavir, while Lamivudine contains Lamivudine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.